Catalyst Wire Dossier Catalyst Wire Dossier

Prophylactic vaccines for Ebola (three heterologous two-dose regimens)

· Janssen Vaccines & Prevention B.V.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Prophylactic vaccines for Ebola (three heterologous two-dose regimens), covering 2021-02-08 to 2021-02-08. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess Safety, Tolerability, and Immunogenicity of Three Heterologus 2-dose Regimens of the Candidate Prophylactic Vaccines for Ebola in Healthy Adults [Phase 2]

See pricing